According to the results, adults taking Mounjaro were more likely to lose 5%, 10% and 15% of their body weight compared to those who were taking Ozempic, which is the brand name for semaglutide
While not a weight loss treatment on their own, the increased energy often helps clients maintain more active lifestyles, which can support weight management goals
Use of GLP-1 drugs is highest among adults who report being diagnosed with conditions these drugs are prescribed to treat, including those who have ever been told by a doctor that they have diabetes (57% ever used, including 45% currently using), heart disease (40% ever, 29% currently), and those that have been told by a doctor that they are overweight or obese in the past five years (34% ever, 23% currently)
This has put executives and business owners in the very uncomfortable position of needing to make medical judgments about their staff, or be seen as taking punitive measures that could affect overall morale